“…Several mechanisms have been suggested (Bowen et al, 1988; Pihusch et al, 2002; Atucha et al, 2007; Witters et al, 2010; Tripodi et al, 2011), including an intrinsic change in platelet function, e.g., increased aggregation resulting from altered intracellular calcium (Ca 2+ ) homeostasis or decreased aggregation due to a storage pool deficiency, the effect of a plasmatic factor such as bile acids or bilirubin or because of the effect of release of ADP-degrading enzymes in the circulation. Regarding platelet activation, the necessary increase in cytoplasmic Ca 2+ levels, both by release from internal stores and entry of extracellular Ca 2+ , has been reported to be defective both in experimental models of liver cirrhosis and patients (Bandi et al, 1997; Atucha et al, 2007; Annie-Jeyachristy et al, 2008). In previous studies from our laboratory, a greater amount of stored Ca 2+ together with an increased activity of SERCA, were observed in platelets obtained from a rat model of biliary cirrhosis (Atucha et al, 2007).…”